Revvity Signals Notebook ELN Review: Features, Pricing & Who It’s For (2026)

Signals Notebook is the flagship ELN of Revvity Signals Software, the informatics division of Revvity, Inc. (NYSE: RVTY). It is the most widely adopted ELN in this review series by any measurable scale: 1 million scientists at 4,000 organisations use it (AWS Marketplace). Named customers include Eli Lilly, Roche Diagnostics, AstraZeneca, Merck KGaA, Lundbeck, Givaudan, and FrieslandCampina. Stanford University and the NIH intramural research programme both run it. Revvity Signals Software employs approximately 720 people and serves those 1 million users worldwide (revvitysignals.com/company/about-us).

Understanding Signals Notebook requires understanding where it comes from. Revvity’s informatics lineage begins with CambridgeSoft, the company that developed ChemDraw in 1985. CambridgeSoft was sold to PerkinElmer in 2011 (Wikipedia), and its lab notebook product — then called E-Notebook — was developed as an enterprise ELN for decades. In 2022, PerkinElmer split into two independent public companies: the life sciences and diagnostics businesses became Revvity, Inc. (NYSE: RVTY); the applied and enterprise businesses kept the PerkinElmer name and went private. Revvity’s software division became Revvity Signals Software, and Signals Notebook is the cloud-native successor to E-Notebook — rebuilt from scratch on a microservice architecture rather than ported to the cloud (white paper, revvitysignals.com).

This article draws on revvitysignals.com (product pages, About Us, case studies, white papers, NEXUS Europe 2025 recap, FAQ pages), the Signals Notebook August 2024 data sheet, the ‘5 Benefits of Signals Notebook’ white paper (January 2025), the Eli Lilly case study (May 2025), AWS Marketplace (product listing and verified reviews), NIH Office of Intramural Research ELN policy (confirmed as active Signals Notebook deployment), Stanford University Science Library (confirmed active licence), G2 (Revvity Signals seller page: 4.4/5, 42 reviews), PeerSpot, ChemDraw Wikipedia article, Wikipedia (Revvity). Revvity Signals has not reviewed, sponsored, or paid for this article.

Company and heritage — why the ChemDraw lineage matters

Revvity is not a startup building a new ELN. It is the scientific informatics arm of a company with 65+ years of history in life sciences and analytical chemistry, with direct lineage to the most trusted chemical drawing tool in existence. This heritage is operationally relevant: Signals Notebook’s native ChemDraw integration is not a partnership or an API connection — ChemDraw is developed by the same organisation, on the same platform, and updated in lockstep with Signals Notebook.

The informatics product line progression is: CambridgeSoft E-Notebook (1990s–2011) → PerkinElmer E-Notebook (2011–2022) → Revvity Signals Notebook (2022–present). Signals Notebook was built cloud-native from the ground up — not a cloud-hosted version of legacy on-premise software. The original E-Notebook product has been sunset. Signals Notebook Standard is the current active product; the Individual Edition reached End of Life on March 1, 2025 (Revvity Signals support portal), with data migration paths to Standard provided.

Revvity Signals Software also maintains an exclusive partnership with Spotfire (the TIBCO/Cloud Software Group data analytics platform), embedding it within the Signals platform for scientific data visualisation. This Spotfire relationship provides advanced analytics capability directly connected to ELN data — a combination that is otherwise unavailable in a single vendor stack from any other ELN in this series.

At a glance

What Signals Notebook does — and what makes it distinct

Signals Notebook’s core function is the same as every ELN in this series: provide a digital replacement for paper lab notebooks that captures experimental data with compliance, searchability, and collaboration. What distinguishes it is the scientific depth of the tooling built into that core, and the scale at which it operates.

Experiment documentation

Scientists create experiment records using flexible templates, rich text formatting, and embedded multimedia. The template system supports both free-form documentation and structured data capture across disciplines: synthetic chemistry, biology, formulations, and analytical work. Templates are highly customisable, and the AWS Marketplace review notes that template updating is “straightforward and everything is automatically saved.” Drag-and-drop file attachment works for a wide variety of data types including raw instrument data files, Office documents (versioned and captured in the audit trail), images, graphs, and videos.

Folder structures are customisable; cross-referencing between experiments is built in; and full-text search across the entire notebook is described by users as “lightning-fast” in the product description. The NIH Office of Intramural Research ELN policy confirms that Signals provides “CFR Part 11 compliant electronic signatures, audit trails, time stamps, page locking, and other features needed to support research expected to generate intellectual property.”

ChemDraw integration — why it matters operationally

For any lab that employs synthetic chemists, this is the critical section. ChemDraw has been the global standard for chemical structure drawing since 1985. More than a quarter century of the world’s published chemistry has been drawn in ChemDraw. Chemists who use ChemDraw every day can work in Signals Notebook without switching applications: draw a reaction, and stoichiometry is calculated automatically; paste a SMILES string or drag a ChemDraw file, and the structure is embedded in the experiment record; search by CAS Number, structure name, or chemical substructure/similarity across the notebook and across all registered materials.

The cloud-native ChemSearch engine (confirmed in the ‘5 Benefits’ white paper) is built on Elastic Search — the same engine behind most modern online search systems — enabling substructure and similarity searching at scale across tens of millions of structures. The 2024 launch of Signals ChemDraw (web-based ChemDraw+) fully integrates ChemDraw with the Signals platform, and AstraZeneca presented at NEXUS Europe 2025 on advanced HELM features in ChemDraw for new modalities including peptides, oligonucleotides, and antibody-drug conjugates.

Collaboration

Signals Notebook is explicitly designed for decentralised and multi-site teams: “a central communication hub across decentralised organizations” (AWS Marketplace). Sharing is granular — notebooks, experiments, and individual pages can be shared with configurable permissions. Commenting, review, approval, and @mention notifications work in real time. The Roche case study (revvitysignals.com) describes a global rollout across research, manufacturing, and quality functions — confirming that the collaboration model scales to large, multi-geography organisations.

Signals DLX — instrument data capture

Signals DLX (Digital Lab Exchange, powered by Scitara Corporation) is the integration layer that connects analytical instruments to Signals Notebook. Without DLX, scientists manually export instrument data files and attach them to ELN entries — a common source of transcription errors and compliance risk. With DLX, instrument data is automatically captured, parsed, and organised into the relevant notebook entry. At NEXUS Europe 2025, Merck Electronics described how they deployed Scitara DLX to capture data from a wide range of analytical instruments and send it both to Signals Notebook and to a relational database for further analysis. Scitara DLX can also act as an AI mediator to integrate APIs across platforms — including with Waters Empower CDS (confirmed at NEXUS Europe 2025).

Inventory management

An inventory module is built directly within Signals Notebook — chemicals, reagents, and samples are tracked without switching systems. Features confirmed on revvitysignals.com: barcode scanning for rapid material capture, built-in location tracking, full material traceability, and automatic low-stock alerts. Merck Electronics presented at NEXUS Europe 2025 on using Signals Notebook Inventory to unify their chemical inventory management across the organisation. This is a direct response to the common pain of ELNs that require a separate inventory system and manual linkage.

Compliance and IP protection

Signals Notebook’s compliance architecture covers the two distinct regulatory environments that pharma and biotech labs navigate:

• 21 CFR Part 11 (FDA electronic records): Automated audit trails with complete change history, configurable electronic signatures, role-based access controls, multi-factor authentication, and version control. The Eli Lilly case study confirms sign/close/witness workflows and the ability to capture reasons for changes as required for 21 CFR Part 11.
• GxP environments (GLP, GMP): GxP-ready with IQ/OQ/PQ templates and validation packages provided by Revvity for regulated deployments. Eli Lilly implemented Signals Notebook in a GxP environment, with Revvity providing comprehensive documentation. NIH OIR confirms: “GxP compliant-ready; suitable for use in user-validated GLP and GMP environments.”
• Intellectual property protection: Sign/close/witness workflows with timestamped, page-locked entries create legally defensible records for IP documentation.
• SOC 2 Type II: Certified — confirms that Revvity’s security controls have been independently audited and verified over time, not just at a single point.
• FedRAMP (US federal government): In progress. NIH OIR confirms Signals Notebook is operating under a provisional ATO with NCATS sponsorship while pursuing full FedRAMP certification. Relevant for US government and federally-funded academic labs.

Signals One — the enterprise evolution

Signals One is positioned as the next layer beyond Signals Notebook, adding AI-enhanced workflows, structured data handling, deeper SAR (structure-activity relationship) insights, and integrated analytics (via Signals Inventa). Per the revvitysignals.com Signals One description: it takes Signals Notebook’s experimental capture, interfaces and integrations, inventory, and material registration and adds “data intelligence, including structured data handling, Signals analytics, SAR analysis and decisioning, and AI enhancement.” For labs moving from paper-based processes, Signals Notebook Standard is the appropriate starting point. For large enterprises with existing Signals Notebook deployments wanting AI-driven decision support, Signals One is the natural evolution.

Named customers and verified context

Signals Notebook has the most extensively documented named customer list of any ELN reviewed in this series. All references below are confirmed from revvitysignals.com customer presentations or named institutional deployments:

Pricing

Revvity does not publish per-user pricing publicly. Signals Notebook Standard Edition is purchasable directly via the Revvity Shop (shop.revvitysignals.com) and the AWS Marketplace, but pricing is not displayed without account engagement. The AWS Marketplace listing confirms pricing is “based on the duration and terms of your contract with the vendor.” Enterprise deployments are quote-based.

Two important product changes to note for lab managers:

• Individual Edition is discontinued (EOL March 1, 2025): The Individual Edition — previously bundled with ChemOffice/ChemDraw licences — reached End of Life on March 1, 2025. Users who had Individual Edition accounts lost access on that date, with data destroyed unless exported or migrated to Standard (Revvity Signals support portal, confirmed). If your organisation previously used Individual Edition, migration to Standard is the supported path.
• Free trial available: A full-featured free trial of Signals Notebook Standard is available at revvitysignals.com with no credit card required. This is the most direct way for lab managers to evaluate the product before engaging the sales team.

Who Signals Notebook is designed for

Based on Revvity’s stated verticals, the named customer base, and the product’s architectural choices, the clearest fit for Signals Notebook is:

• Pharmaceutical and biopharma R&D and development organisations whose scientists work in synthetic chemistry, medicinal chemistry, or chemical biology — where native ChemDraw is not a nice-to-have but a daily workflow requirement. If your chemists currently draw structures in ChemDraw and copy them into a separate ELN, Signals Notebook eliminates that friction entirely.
• Global, multi-site R&D organisations that need real-time collaboration across geographies and time zones. The product’s cloud-native architecture, combined with the named deployments at Eli Lilly, Roche, AstraZeneca, and Merck KGaA, confirms the enterprise-scale, multi-site model is production-tested.
• Regulated labs (GxP, 21 CFR Part 11) that need a cloud ELN with validated compliance workflows and IQ/OQ/PQ documentation support. The Eli Lilly GxP case study is the most specific validated production evidence in this series.
• Chemicals, materials science, food and fragrance, and flavour labs that work with chemical structures and formulations. Revvity’s verticals explicitly include specialty and agro-chemicals, energy and petrochemicals, flavors and fragrances, and food and beverage — and named customers Givaudan and FrieslandCampina confirm real deployments in those sectors.
• University and academic research groups that have institutional ChemDraw licences (Stanford, NIH) and want a cloud ELN that works within that same vendor relationship.
• Labs standardising on a cloud-native architecture with automatic updates, no on-premise infrastructure, and flexible scaling for growing teams.

Signals Notebook is less commonly the right choice for:

• Labs whose primary discipline is biology, genomics, or molecular biology — where ChemDraw is not central to daily work. In those environments, Benchling (with deep molecular biology tooling), SciSure, or Labguru may provide equal or better value without paying for ChemDraw capability that goes unused.
• Labs that require on-premise deployment for data sovereignty or IT governance reasons. Signals Notebook is cloud-only (AWS). For on-premise ELN, BIOVIA Notebook, E-WorkBook, or Sapio Sciences are better positioned.
• Small labs or individual researchers on tight budgets who were relying on the Individual Edition. That product is now End of Life. Signals Notebook Standard requires a licence engagement with Revvity. Free open-source alternatives like eLabFTW, or lower-cost commercial ELNs like Labguru, are better positioned for small teams.
• Labs that need a fully integrated LIMS+ELN in a single product. Signals Notebook is an ELN that integrates with external LIMS via API. For a unified LIMS+ELN from a single vendor, BIOVIA ONE Lab, Sapio Sciences, or Labguru may be more appropriate.

What users say

Revvity Signals products are rated 4.4/5 from 42 verified G2 reviews (G2 seller page, April 2026). AWS Marketplace surfaces reviews from both G2 and PeerSpot for Signals Notebook specifically. The overall pattern from independent reviews is positive on core functionality and negative on workflow complexity and support responsiveness.

What users praise

• Ease of use: Multiple reviewers describe Signals Notebook as intuitive and modern, “looks and feels like modern consumer apps.” One AWS/G2 reviewer rates it 9/10 specifically because of ease of use.
• Cross-site collaboration: A chemical process development user describes compiling data from multiple projects and working across two sites in different cities as a concrete operational improvement: “we can work on one experiment across different sites of the company.”
• Template system: Reviewers describe templates as easy to create and update, significantly reducing repetitive data entry. “We can use templates for experiment creation, allowing us to avoid repetitive tasks.”
• Stability at scale: One reviewer describes deploying to nearly 100,000 users in a single client environment, describing Signals Notebook as stable at that scale. “Since it was developed from scratch, it is a very stable product.”
• Speed vs. legacy systems: Signals Notebook is described as swift compared to other vendor-built software where “you have to customize templates and write a lot of code.”

What users criticise

• Workflow implementation: The most consistent criticism is that complex workflows rely on Spotfire with added plugins that are not natively integrated into Signals Notebook. One reviewer states this “makes execution slow and less effective in meeting all scientific workflow needs” and that Revvity’s workflow products outside core Signals Notebook are described as less stable. This is a meaningful distinction: Signals Notebook core is praised; the ecosystem products connecting it to analytics are described as less mature.
• Support responsiveness: Multiple reviewers independently describe support response times as slow. “Even known problems take time due to a lack of a strong developer support team.” This is the most consistent negative across independent reviews.
• Complex data integration requires developer resources: For advanced data integration beyond the standard product, reviewers note that using Revvity’s REST API to expose data to a data lake “can be costly and resource-intensive.” One reviewer explicitly advises evaluating whether complex analytics use cases are achievable before committing.
• Overall rating context: One reviewer rates Signals Notebook 6/10 due to concern about Revvity’s focus being narrowed to core products while peripheral products receive less attention. This is a single data point but worth noting for labs that plan to use the full Signals ecosystem rather than Signals Notebook alone.

Quick verdict

Further reading

• Signals Notebook official product page
• Signals Notebook free trial
• Eli Lilly GxP implementation case study (May 2025)
• 5 Benefits of Signals Notebook — white paper (January 2025)
• Signals Notebook August 2024 data sheet
• NEXUS Europe 2025 — customer presentations recap (AstraZeneca, Roche, Merck KGaA, Lundbeck, Givaudan)
• Industry peer use case presentations (Eli Lilly, Roche, Merck Electronics)
• Revvity Signals About Us (720 employees, 1M users)
• Signals Notebook on AWS Marketplace (verified reviews)
• NIH OIR ELN Policy (confirms active deployment and FedRAMP status)
• Sunset Notice: Signals Notebook Individual Edition (EOL March 1, 2025)
• Revvity — Wikipedia (company history and PerkinElmer split)
• ChemDraw — Wikipedia (CambridgeSoft history, 1985 origins)
• labsoftwareguide.com: Best ELN Software 2026